
Diego Velázquez
CEO of Senda
Co-founder and CEO of Bio-Omix, an expert in data analysis. A doctoral student in Biomedicine and Genomic Medicine and a researcher at the Instituto Nacional de Medicina Genómica (INMEGEN), where he works on developing a metabolomic biomarker for the early diagnosis of gestational diabetes. Winner of the Premio Juventud Ciudad de México 2025 in Science and Innovation and of the Premio de Innovación Farmacéutica 2025.

